Published in Proc Soc Exp Biol Med on November 01, 1970
Chemicals, drugs, and lipid peroxidation. Annu Rev Pharmacol Toxicol (1976) 1.45
Studies on the mechanism of phenobarbital-enhanced sulfobromophthalein disappearance. J Pharmacol Exp Ther (1968) 1.37
Intrahepatic cholestasis induced by drugs and chemicals. Pharmacol Rev (1976) 1.21
Comparison of the biochemical alterations elicited in livers from rats treated with carbon tetrachloride, chloroform, 1,1,2-trichloroethane and 1,1,1-trichloroethane. Biochem Pharmacol (1969) 1.20
Chlorinated hydrocarbon toxicity. Potentiation by isopropyl alcohol and acetone. Arch Environ Health (1974) 1.14
Effect of phenobarbital on the excretion of an exogenous bilirubin load. Biochem Pharmacol (1967) 1.14
Maximum biliary excretion of bilirubin and sulfobromophthalein during anesthesia-induced alteration of rectal temperature. Proc Soc Exp Biol Med (1967) 1.07
Hepatic subcellular distribution of manganese in manganese and manganese-bilirubin induced cholestasis. Biochem Pharmacol (1985) 1.07
Differences in the potentiation of carbon tetrachloride in rats by ethanol and isopropanol pretreatment. Toxicol Appl Pharmacol (1971) 1.06
Plasma disappearance and biliary excretion of indocyanine green in rats, rabbits, and dogs. Toxicol Appl Pharmacol (1969) 0.98
Relationship of alcohol metabolism to the potentiation of CCl 4 hepatotoxicity induced by aliphatic alcohols. J Pharmacol Exp Ther (1972) 0.97
Relative effects of various chlorinated hydrocarbons on liver and kidney function in mice. Toxicol Appl Pharmacol (1966) 0.97
Functional changes of the biliary tree associated with experimentally induced cholestasis: sulfobromophthalein on manganese-bilirubin combinations. Toxicol Appl Pharmacol (1991) 0.97
The nature of alpha-naphthylisothiocyanate-induced cholestasis. Toxicol Appl Pharmacol (1965) 0.96
Choleretic and cholestatic effects of infused bile salts in the rat. Experientia (1979) 0.95
Species variation in metabolism, storage, and excretion of sulfobromophthalein. Am J Physiol (1967) 0.94
Relative effects of various chlorinated hydrocarbons on liver and kidney function in dogs. Toxicol Appl Pharmacol (1967) 0.92
Alteration of the plasma disappearance and biliary excretion patterns of exogenously administered bilirubin by alpha-nephthylisothiocyanate. J Pharmacol Exp Ther (1967) 0.91
Maximal biliary excretion of bilirubin and sulfobromophthalein during various rates of infusion in rats of different weights and strains. Toxicol Appl Pharmacol (1969) 0.90
Effect of simultaneous exposure to toluene and xylene on their respective biological exposure indices in humans. Int Arch Occup Environ Health (1991) 0.89
Determination of sulfobromophthalein storage and exertory rate in small animals. J Appl Physiol (1967) 0.88
Induction of microsomal drug metabolism in man and in the rat by exposure to petroleum. Br J Ind Med (1981) 0.88
Acute alteration of chloroform-induced hepato- and nephrotoxicity by n-hexane, methyl n-butyl ketone, and 2,5-hexanedione. Toxicol Appl Pharmacol (1980) 0.88
Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy. Aust N Z J Med (1977) 0.86
Effect of halogenated hydrocarbons on organic ion accumulation by renal cortical slices of rats and mice. Toxicol Appl Pharmacol (1972) 0.85
Toxicity of halogenated volatile anesthetics in isolated rat hepatocytes. Anesthesiology (1978) 0.85
alpha-Naphthylisothiocyanate (ANIT) hepatotoxicity and irreversible binding to rat liver microsomes. Biochem Pharmacol (1977) 0.84
Isopropanol and acetone potentiation of carbon tetrachloride-induced hepatotoxicity: single versus repetitive pretreatments in rats. J Toxicol Environ Health (1982) 0.83
Potentiation of thioacetamide-induced hepatotoxicity in alloxan- and streptozotocin-diabetic rats. Toxicol Lett (1983) 0.83
Pathogenesis of lithocholate-induced intrahepatic cholestasis: role of glucuronidation and hydroxylation of lithocholate. Biochim Biophys Acta (1992) 0.83
Acute toxicity of antiepileptic drugs. Epilepsia (1975) 0.82
Correlation between acetone-potentiated CCl4-induced liver injury and blood concentrations after inhalation or oral administration. Toxicol Appl Pharmacol (1986) 0.82
Quantitative and temporal delineation of various parameters of liver dysfunction due to alpha-naphthylisothiocyanate. Toxicol Appl Pharmacol (1965) 0.81
Monohydroxy bile acid induced cholestasis: role of biotransformation. Drug Metab Rev (1997) 0.81
Relationship between the carbon skeleton length of ketonic solvents and potentiation of chloroform-induced hepatotoxicity in rats. Toxicol Lett (1983) 0.80
Catecholamine potentiation of carbon tetrachloride-induced hepatotoxicity in mice. Toxicol Appl Pharmacol (1969) 0.80
Functional effects of -naphthylisothiocyanate in various species. Toxicol Appl Pharmacol (1971) 0.80
The effect of SKF 525A on the distribution of carbon tetrachloride in rats. J Pharmacol Exp Ther (1970) 0.80
Peroxisome proliferators protect against paracetamol hepatotoxicity in mice. Biochem Pharmacol (1992) 0.80
Effect of dosing vehicle on the hepatotoxicity of CCl4 and nephrotoxicity of CHCl3 in rats. J Toxicol Environ Health (1997) 0.80
Rat hepatocytes with elevated metallothionein expression are resistant to N-methyl-N'-nitro-N-nitrosoguanidine cytotoxicity. Toxicol Appl Pharmacol (1996) 0.80
Potentiation and inhibition of alpha-naphthylisothiocyanate-induced hyperbilirubinemia and cholestasis. J Pharmacol Exp Ther (1965) 0.80
Clofibrate pretreatment in mice confers resistance against hepatic lipid peroxidation. J Biochem Mol Toxicol (2000) 0.79
Extrarenal excretion of drugs and chemicals. Annu Rev Pharmacol (1968) 0.79
Acetone-induced potentiation of trihalomethane toxicity in male rats. Toxicol Lett (1983) 0.79
Clofibrate-induced in vitro hepatoprotection against acetaminophen is not due to altered glutathione homeostasis. Toxicol Sci (2000) 0.79
Protection by 2-diethylaminoethyl-2,2-diphenylvalerate hydrochloride against carbon tetrachloride hepatotoxicity. A possible mechanism of action. Biochem Pharmacol (1971) 0.79
Functional aspects of the cholestatic response induced by -naphthylisothiocyanate in mice and rats. Agents Actions (1969) 0.79
Sulfobromophthalein metabolism and excretion in rats with iodomethane-induced depletion of hepatic glutathione. J Pharmacol Exp Ther (1970) 0.79
Temporal aspects of carbon tetrachloride-induced alteration of sulfobromophthalein excretion and metabolism. Toxicol Appl Pharmacol (1970) 0.79
Modification of haloalkane-induced hepatotoxicity by exogenous ketones and metabolic ketosis. Fed Proc (1980) 0.79
Evaluation of health aspects of GRAS food ingredients: lessons learned and questions unanswered. Fed Proc (1977) 0.79
Protein binding and the excretion of some azo dyes in rat bile. J Pharm Pharmacol (1966) 0.79
Sister chromatid exchanges in lymphocytes of petroleum retailers. Br J Ind Med (1993) 0.78
Lipid peroxidation in isolated rat hepatocytes: relationship to toxicity of CCl4, ADP/Fe3+, and diethyl maleate. Toxicol Appl Pharmacol (1978) 0.78
Ketone potentiation of haloalkane-induced hepato- and nephrotoxicity. II. Implication of monooxygenases. J Toxicol Environ Health (1995) 0.78
Urinary thioether output as an index of occupational chemical exposure in petroleum retailers. Br J Ind Med (1986) 0.78
Pretreatment with peroxisome proliferators protects mice against some but not all hepatotoxins. Ann N Y Acad Sci (1996) 0.78
Biochemical and morphological parameters of taurolithocholate-induced cholestasis. Can J Physiol Pharmacol (1971) 0.78
Effect of norethandrolone, acetohexamide, and Enovid on alpha-naphthylisothiocyanate-induced hyperbilirubinemia and cholestasis. Biochem Pharmacol (1966) 0.78
Potentiation of the hepatotoxic responses to chemicals in alloxan-diabetic rats. Proc Soc Exp Biol Med (1975) 0.78
Microsomal drug metabolism during alpha-naphthylisothiocyanate-induced cholestasis. Toxicol Appl Pharmacol (1976) 0.78
Altered drug metabolism in anaesthetists exposed to volatile anaesthetic agents. Anaesth Intensive Care (1978) 0.78
Dose-dependent modification of 1,1-dichloroethylene toxicity by acetone. Toxicol Lett (1983) 0.78
Measurement of hepatic blood flow by a thermodilution method. J Appl Physiol (1967) 0.77
Hemodynamic effects of CCl4 in the intact liver of the cat. Can J Physiol Pharmacol (1974) 0.77
Effects of acetone and methyl n-butyl ketone on hepatic mixed-function oxidase. Biochem Pharmacol (1989) 0.77
Role of perivenous hepatocytes in taurolithocholate-induced cholestasis in vivo. Toxicol Lett (2000) 0.77
Induction of metallothionein gene expression by epidermal growth factor and its inhibition by transforming growth factor-beta and dexamethasone in rat hepatocytes. Hepatology (1995) 0.77
Phenobarbitone and biliary excretion. Lancet (1968) 0.77
Potentiation of carbon tetrachloride-induced hepatotoxicity in alloxan- or strepto- zotocin-diabetic rats. J Pharmacol Exp Ther (1975) 0.77
Potentiation of chloroform-induced hepatotoxicity by methyl isobutyl ketone and two metabolites. Can J Physiol Pharmacol (1990) 0.77
Implication of alterations in intracellular calcium ion homoeostasis in the advent of paracetamol-induced cytotoxicity in primary mouse hepatocyte monolayer cultures. Toxicol In Vitro (1990) 0.77
Effect of aminotriazole on isopropanol- and acetone-induced potentiation of CCl 4 hepatotoxicity. Can J Physiol Pharmacol (1973) 0.77
Phase I and phase II metabolism of lithocholic acid in hepatic acinar zone 3 necrosis. Evaluation in rats by combined radiochromatography and gas-liquid chromatography-mass spectrometry. Biochem Pharmacol (1994) 0.77
Methyl isobutyl ketone metabolites and potentiation of the cholestasis induced in rats by a manganese-bilirubin combination or manganese alone. Toxicol Appl Pharmacol (1988) 0.77
Tissue concentrations of methyl isobutyl ketone, methyl n-butyl ketone and their metabolites after oral or inhalation exposure. Toxicol Lett (1995) 0.77
Metabolic fate of methyl n-butyl ketone, methyl isobutyl ketone and their metabolites in mice. Toxicol Lett (1994) 0.77
The nephrotoxicity of single and multiple doses of aliphatic chlorinated hydrocarbon solvents in male mice. Toxicol Appl Pharmacol (1972) 0.77
Ketone potentiation of haloalkane-induced hepato- and nephrotoxicity. I. Dose-response relationships. J Toxicol Environ Health (1995) 0.77
Studies on bilirubin production and excretion in mice and rats treated with phenobarbital, chlorpromazine, norethandrolone, acetohexamide or enovid. Toxicol Appl Pharmacol (1969) 0.77
Acute alteration of chloroform-induced hepato- and nephrotoxicity by Mirex and Kepone. Toxicol Appl Pharmacol (1979) 0.76
The role of acinar zone 3 hepatocytes in bile formation: influence of bromobenzene treatment on bile formation in the rat. Liver (1990) 0.76
Effect of occupational exposure to aldrin on urinary D-glucaric acid, plasma dieldrin, and lymphocyte sister chromatid exchange. Int Arch Occup Environ Health (1994) 0.76
Taurolithocholate-induced intrahepatic cholestasis: potentiation by methyl isobutyl ketone and methyl n-butyl ketone in rats. Toxicol Appl Pharmacol (1985) 0.76
Role of the enterohepatic circulation in the elimination of phenytoin in the rat. Drug Metab Dispos (1978) 0.76
The role of biotransformation-detoxication in acetone-, 2-butanone-, and 2-hexanone-potentiated chloroform-induced hepatotoxicity. Can J Physiol Pharmacol (1987) 0.76
Effects of benziodarone on the metabolism and biliary excretion of sulfobromophthalein and related dyes. Proc Soc Exp Biol Med (1969) 0.76
Evidence for the involvement of organelles in the mechanism of ketone-potentiated chloroform-induced hepatotoxicity. Liver (1990) 0.76
Impairment of hepatic drug metabolism in alcoholics. Br J Clin Pharmacol (1979) 0.75
Morphological aspects of manganese-bilirubin induced cholestasis. Liver (1982) 0.75
Influence of various mixtures of inhaled toluene and xylene on the biological monitoring of exposure to these solvents in rats. Can J Physiol Pharmacol (1992) 0.75
Quantitative aspects in the assessment of liver injury. Environ Health Perspect (1976) 0.75
Metabolic alterations in organ function. J Assoc Off Anal Chem (1975) 0.75
The effects of cycloheximide, actinomycin D, and ethionine on the biliary excretion of labelled alpha-naphthylisothiocyanate in rats. Exp Mol Pathol (1975) 0.75